Immunocomplex kinase assays for ERK and GSK3β activity without FGF2 treatment, or after inhibition with PD98059, U0126, LY29004, Bisindolymaleimide I or Gö6983 followed by FGF2 treatment
Year: 2011
Type: other
Abstract: Copyright information:Taken from "Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120"BMC Neuroscience 2005;6():8-8.Published online 2 Feb 2005PMCID:PMC549045.Copyright © 2005 Langford et al; licensee BioMed Central Ltd. Inhibitor treatment alone. () Summary of changes in phosphorylation (P) versus changes in activity (Act) of ERK and GSK3β. ⇑ Indicates an increase, ⇓ indicates a decrease, – indicates no change. * = P < 0.05 by One-Way ANOVA with post-hoc Dunnett's when compared to control.
Source: Figshare
Authors: Langford, Dianne, Hurford, Rosemary, Hashimoto, Makoto, Digicaylioglu, Murat, Masliah, Eliezer
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W6902084846